HF
RCEL icon

HRT Financial’s Avita Medical RCEL Stock Holding History

HRT Financial’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-93,026
Closed -$475K – 3880
2025
Q3 		$475K Buy
+93,026
New +$485K ﹤0.01% 1928
2023
Q2 		– Sell
-11,522
Closed -$160K – 3125
2023
Q1 		$160K Buy
+11,522
New +$123K ﹤0.01% 1968
2022
Q2 		– Sell
-15,991
Closed -$135K – 3588
2022
Q1 		$135K Buy
+15,991
New +$147K ﹤0.01% 2591

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's RCEL Position: Q4 2025 in Review

HRT Financial sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 93,026 shares — an estimated $475K sold.

HRT Financial first reported a position in RCEL in Q1 2022 and held it in 3 quarters. The position peaked at $475K in Q3 2025. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

  • HRT Financial reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 93,026 Avita Medical shares in Q4 2025, an estimated $475K.
  • HRT Financial first reported a position in Avita Medical in Q1 2022 and held it in 3 quarters.
  • HRT Financial's Avita Medical position peaked at $475K in Q3 2025.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.